# Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

> **NCT03178929** · NA · UNKNOWN · sponsor: **Beijing Insight Science & Technology Co. Ltd.** · enrollment: 207 (estimated)

## Conditions studied

- Primary Liver Cancer

## Interventions

- **DRUG:** S-Adenosyl Methionine

## Key facts

- **NCT ID:** NCT03178929
- **Lead sponsor:** Beijing Insight Science & Technology Co. Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-08-31
- **Target enrollment:** 207 (ESTIMATED)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178929, "Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03178929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*